Robot Mediated Therapy-Upper Limb Outcomes in Stroke
Stroke, Acute
About this trial
This is an interventional treatment trial for Stroke, Acute
Eligibility Criteria
Inclusion Criteria: Diagnosis of stroke as evidenced by CT/MRI findings First-ever stroke (ischaemic or haemorrhagic) Upper limb weakness and an FMA-UE score of 16-53 (severe to moderate: 16-34. moderate to mild: 35-53)12,13 Cognitively intact to follow instructions Medically stable to participate Consent given Age 21 and above Exclusion Criteria: 1. Fractures or other musculoskeletal issues that render the use of the robotic device unsuitable 2. Involvement in another concurrent upper limb study 3. Wounds that do not allow donning of the device 4. Severe spasticity 5. Cognitive impairment (MMSE ≤20) 6. Inability to follow instructions 7. Severe osteoporosis 8. Infectious diseases that require the patient to be isolated in a single room eg airborne diseases -
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Robot mediated Impairment-oriented training(RMIT)
Robot mediated impairment-oriented and task-specific training (RMIT+RMTT)
Participant receives 20 hours of robot mediated impairment-oriented training applied via the Optimo Regen
Participant receives a total of 20 hours of robotic therapy. 10 hours will be in the form of RMIT and 10 hours in the form of RMTT